Mats Remberger

Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation

Moya, Tommy Alfaro; Carreira, Abel Santos; Chen, Shiyi; Remberger, Mats et al.

Part of PLOS ONE, 2025

• DOI for Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation
• Download full text (pdf) of Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation

Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation

Herrity, Elizabeth; Singhabahu, Sanjay; Remberger, Mats; Moya, Tommy Alfaro et al.

Part of Cancers, 2025

• DOI for Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation
• Download full text (pdf) of Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation

Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?

Alnughmush, Ahmed; Sayyed, Ayman; Remberger, Mats; AL-Shaibani, Eshrak et al.

Part of Transplantation direct, 2025

• DOI for Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?
• Download full text (pdf) of Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?

PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation

Desai, Nihar; Altareb, Majed; Remberger, Mats; Chen, Carol et al.

Part of Blood Advances, 2024

• DOI for PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation
• Download full text (pdf) of PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Gronvold, B. Linder; Ali, Maryan Mohamed; Myklebust, Tor Å; Lenartova, Andrea et al.

Part of eJHaem, p. 117-124, 2024

• DOI for Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
• Download full text (pdf) of Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation

Moya, Tommy Alfaro; Carreira, Abel Santos; Chen, Shiyi; Remberger, Mats et al.

Part of PLOS ONE, 2025

• DOI for Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation
• Download full text (pdf) of Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation

Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation

Herrity, Elizabeth; Singhabahu, Sanjay; Remberger, Mats; Moya, Tommy Alfaro et al.

Part of Cancers, 2025

• DOI for Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation
• Download full text (pdf) of Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation

Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?

Alnughmush, Ahmed; Sayyed, Ayman; Remberger, Mats; AL-Shaibani, Eshrak et al.

Part of Transplantation direct, 2025

• DOI for Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?
• Download full text (pdf) of Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?

PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation

Desai, Nihar; Altareb, Majed; Remberger, Mats; Chen, Carol et al.

Part of Blood Advances, 2024

• DOI for PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation
• Download full text (pdf) of PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Gronvold, B. Linder; Ali, Maryan Mohamed; Myklebust, Tor Å; Lenartova, Andrea et al.

Part of eJHaem, p. 117-124, 2024

• DOI for Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
• Download full text (pdf) of Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study

Pasic, Ivan; Moya, Tommy Alfaro; Remberger, Mats; Chen, Carol et al.

Part of Transplantation and Cellular Therapy, p. 6810-68100000000000, 2024

• DOI for Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study

Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data

Pang, Ian; Chen, Peggy; Trinh, Gertrude V.; Remberger, Mats et al.

Part of European Journal of Haematology, p. 301-309, 2024

• DOI for Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Gerbitz, Armin; Gary, Regina; Aigner, Michael; Moosmann, Andreas et al.

Part of Frontiers in Immunology, 2023

• DOI for Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
• Download full text (pdf) of Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Pereira, Mariana Pinto; Remberger, Mats; Chen, Carol; Gerbitz, Armin et al.

Part of Transplantation and Cellular Therapy, 2023

• DOI for Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation

Carreira, Abel Santos; Salas, Maria Queralt; Remberger, Mats; Novitzky-Basso, Igor et al.

Part of Transplantation and Cellular Therapy, p. 5810-58100000000, 2023

• DOI for Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation

Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden

Schain, Frida; Boissin, Constance; Laczik, Tamas; Fedeli, Stefano et al.

Part of Transfusion and apheresis science, 2023

• DOI for Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden
• Download full text (pdf) of Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden

Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease

Novitzky-Basso, Igor; Schain, Frida; Batyrbekova, Nurgul; Webb, Thomas et al.

Part of PLOS ONE, 2023

• DOI for Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease
• Download full text (pdf) of Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease

COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis

Lim, Yeong Jer; Khan, Umair; Karpha, Indrani; Ross, Andrew et al.

Part of eJHaem, p. 862-872, 2022

• DOI for COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis
• Download full text (pdf) of COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis

Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study

Carreira, Abel Santos; Salas, Maria Queralt; Remberger, Mats; Basso, Igor Novitzky et al.

Part of Transplantation and Cellular Therapy, p. 500-5000000000, 2022

• DOI for Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study

Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation

Prem, Shruti; Remberger, Mats; Alotaibi, Ahmad; Lam, Wilson et al.

Part of Transplant Infectious Disease, 2022

• DOI for Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation

Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups

Garcia‐Horton, Alejandro; Cyriac, Sunu L.; Gedde‐Dahl, Tobias; Floisand, Yngvar et al.

Part of European Journal of Haematology, p. 672-679, 2022

• DOI for Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups

The impact of transportation time on apoptosis in allogeneic stem cell grafts and the clinical outcome in malignant patients with unrelated donors

Wang, Tengyu; Remberger, Mats; Bjorklund, Andreas; Watz, Emma

Part of Cytotherapy, p. 508-515, 2022

• DOI for The impact of transportation time on apoptosis in allogeneic stem cell grafts and the clinical outcome in malignant patients with unrelated donors
• Download full text (pdf) of The impact of transportation time on apoptosis in allogeneic stem cell grafts and the clinical outcome in malignant patients with unrelated donors

Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience

Salas, Maria Queralt; Pasic, Ivan; Remberger, Mats; Novitzky-Basso, Igor et al.

Part of Transplantation and Cellular Therapy, 2022

• DOI for Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience

Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors

Novitzky‐Basso, Igor; Remberger, Mats; Chen, Carol; Ellison, Cynthia et al.

Part of European Journal of Haematology, p. 288-297, 2022

• DOI for Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors

Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts

Novitzky‐Basso, Igor; Remberger, Mats; Chen, Carol; Pasić, Ivan et al.

Part of European Journal of Haematology, p. 61-72, 2021

• DOI for Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts
• Download full text (pdf) of Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts

Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival

Ali, M. M.; Gronvold, B.; Remberger, Mats; Abrahamsen, I. W. et al.

Part of Clinical Lymphoma, Myeloma & Leukemia, p. 598-605, 2021

• DOI for Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival

Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care

Ringdén, Olle; Remberger, Mats; Törlén, Johan; Finnbogadottir, Sigrun et al.

Part of International Journal of Hematology, p. 712-722, 2021

• DOI for Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care

Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease

Schain, Frida; Batyrbekova, Nurgul; Liwing, Johan; Baculea, Simona et al.

Part of European Journal of Health Economics, p. 169-180, 2021

• DOI for Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease
• Download full text (pdf) of Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease

Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG

Remberger, Mats; Tjønnfjord, Geir E.; Abrahamsen, Ingerid W.; Ali, Maryan et al.

Part of Transplantation and Cellular Therapy, p. 6210-621000, 2021

• DOI for Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG
• Download full text (pdf) of Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis

Garming-Legert, Karin; Ringdén, Olle; Remberger, Mats; Törlén, Johan et al.

Part of Oral Diseases, p. 1217-1225, 2020

• DOI for Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis
• Download full text (pdf) of Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis

Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis

Tollemar, Victor; Tudzarovski, Nikcole; Warfvinge, Gunnar; Yarom, Naom et al.

Part of Biology of blood and marrow transplantation, p. 1971-1979, 2020

• DOI for Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis
• Download full text (pdf) of Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis

Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c⁺ Expression in Tumor

Magalhaes, Isabelle; Fernebro, Josefin; Abd Own, Sulaf; Glaessgen, Daria et al.

Part of Advances in Therapy, p. 5023-5031, 2020

• DOI for Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c⁺ Expression in Tumor
• Download full text (pdf) of Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c⁺ Expression in Tumor

The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors

Remberger, Mats; Grønvold, B.; Ali, M.; Mattsson, J. et al.

Part of Clinical Hematology International, p. 74-81, 2020

• DOI for The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors
• Download full text (pdf) of The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors

Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Cheng, Guang‐Shing; Selwa, Katherine E.; Hatt, Charles; Ram, Sundaresh et al.

Part of American Journal of Transplantation, p. 2198-2205, 2020

• DOI for Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategies

Prem, Shruti; Remberger, Mats; Salas, Maria Queralt; Al-Shaibani, Zeyad et al.

Part of Bone Marrow Transplantation, p. 689-691, 2020

• DOI for Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategies

Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation

El-Serafi, Ibrahim; Remberger, Mats; Ringdén, Olle; Törlén, Johan et al.

Part of Clinical and Translational Science, p. 293-300, 2020

• DOI for Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
• Download full text (pdf) of Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation

High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis

Queralt Salas, Maria; Prem, Shruti; Remberger, Mats; Lam, Wilson et al.

Part of Leukemia and Lymphoma, p. 3198-3208, 2020

• DOI for High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis

HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation

Grønvold, B.; Ali, M. M.; Remberger, Mats; Mattsson, J. et al.

Part of Bone Marrow Transplantation, p. 1658-1661, 2020

• DOI for HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation

Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease

Sadeghi, Behnam; Remberger, Mats; Gustafsson, Britt; Winiarski, Jacek et al.

Part of Biology of blood and marrow transplantation, p. 1965-1969, 2019

• DOI for Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease
• Download full text (pdf) of Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease

The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease

Svenberg, Petter; Wang, Tengyu; Uhlin, Michael; Watz, Emma et al.

Part of Clinical Transplantation, 2019

• DOI for The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor

Ringden, Olle; Remberger, Mats; Gustafsson, Britt; Moretti, Gianluca et al.

Part of Transplantation, p. 1247-1252, 2019

• DOI for The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor